Literature DB >> 18107422

Alloxan and dialuric acid; their stabilities and ultraviolet absorption spectra.

J W PATTERSON, A LAZAROW.   

Abstract

Entities:  

Keywords:  ACID/dialuric; ALLOXAN; ULTRAVIOLET RAYS

Mesh：

Substances：

Year:  1949        PMID： 18107422

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  [Importance of method of administration of alioxan in rats].

Authors:  V FISTER; L RABADJIJA; D BAIC
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1957

2.  The mechanism of alloxan toxicity: an indication for alloxan complexes in tissues and alloxan inhibition of 4-acetamido-4'-isothiocyanato-stilbene-2,2'-disulphonic acid (SITS) binding for the liver cell membrane.

Authors:  N Bilić
Journal:  Diabetologia       Date:  1975-02       Impact factor: 10.122

Review 3.  Alloxan: history and mechanism of action.

Authors:  S Lenzen; U Panten
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

4. 

Authors:  Doddy A Tisna-Amidjaja
Journal:  Wilhelm Roux Arch Entwickl Mech Org       Date:  1958-11

5.  The effect of oxine and alloxan on the sulfide silver stainability of the rat brain.

Authors:  G Danscher; K Fredens
Journal:  Histochemie       Date:  1972

6.  Factors affecting the inhibition by alloxan, and effect of streptozotocin on phosphate transport in isolated mouse mitochondria.

Authors:  L Nelson; L Boquist
Journal:  Acta Diabetol Lat       Date:  1982 Oct-Dec

Review 7.  The mechanisms of alloxan- and streptozotocin-induced diabetes.

Authors:  S Lenzen
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

8.  Evaluation of the Hypoglycemic Properties of Anacardium humile Aqueous Extract.

Authors:  Márcio A Urzêda; Silvana Marcussi; Luciana L Silva Pereira; Suzelei C França; Ana Maria S Pereira; Paulo S Pereira; Saulo L da Silva; César L S Guimarães; Leonardo A Calderon; Rodrigo G Stábeli; Andreimar M Soares; Lucélio B Couto
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.